Robotic-assisted pancreaticoduodenectomy with vascular resection. Description of the surgical technique and analysis of early outcomes.


Journal

Surgical oncology
ISSN: 1879-3320
Titre abrégé: Surg Oncol
Pays: Netherlands
ID NLM: 9208188

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 21 12 2019
revised: 03 05 2020
accepted: 19 08 2020
pubmed: 27 9 2020
medline: 13 10 2021
entrez: 26 9 2020
Statut: ppublish

Résumé

Despite the potential benefits, the adoption of the minimally invasive surgery for the treatment of borderline resectable pancreatic cancer is still in the initial phase. We investigated the safety and feasibility of the robotic pancreaticoduodenectomy with venous resection/reconstruction (RPD SMV/PV). Since March 2013 to October 2019, a total of 73 RPD and 10 RPD SMV/PV were performed. The two groups were case-matched according to the preoperative characteristics. Mean operative times and estimated blood loss were less in the RPD group in comparison to that in the RPD with SMV-PV group (525 vs 642 min, p = 0.003 and 290 vs 620 ml, p = 0.002, respectively). The mean length of hospital stay was similar in the RPD group in comparison to that in the RPD with SMV-PV group (10 days vs 13 days, p = 0.313). The two groups had similar overall postoperative morbidity rate (57.5% vs 60%, p = 0.686), although the severe complication rate was lower in the RPD group (11% vs 40%, p = 0.004). RPD with SMV-PV is associated with increased operative time, estimated blood loss, higher major complication rate compared with RPD.

Sections du résumé

BACKGROUND BACKGROUND
Despite the potential benefits, the adoption of the minimally invasive surgery for the treatment of borderline resectable pancreatic cancer is still in the initial phase. We investigated the safety and feasibility of the robotic pancreaticoduodenectomy with venous resection/reconstruction (RPD SMV/PV).
METHODS METHODS
Since March 2013 to October 2019, a total of 73 RPD and 10 RPD SMV/PV were performed. The two groups were case-matched according to the preoperative characteristics.
RESULTS RESULTS
Mean operative times and estimated blood loss were less in the RPD group in comparison to that in the RPD with SMV-PV group (525 vs 642 min, p = 0.003 and 290 vs 620 ml, p = 0.002, respectively). The mean length of hospital stay was similar in the RPD group in comparison to that in the RPD with SMV-PV group (10 days vs 13 days, p = 0.313). The two groups had similar overall postoperative morbidity rate (57.5% vs 60%, p = 0.686), although the severe complication rate was lower in the RPD group (11% vs 40%, p = 0.004).
CONCLUSIONS CONCLUSIONS
RPD with SMV-PV is associated with increased operative time, estimated blood loss, higher major complication rate compared with RPD.

Identifiants

pubmed: 32979700
pii: S0960-7404(20)30373-X
doi: 10.1016/j.suronc.2020.08.025
pii:
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

344-350

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Marco Vito Marino (MV)

Department of Emergency and General Surgery, Azienda Ospedaliera, Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy; Department of General and Digestive Surgery, Hospital Universitario Marqués de Valdecilla, Santander, Spain; Department of Surgical, Oncological and Oral Science, Palermo University Hospital, Palermo, Italy; General Surgery Department, Policlinico Abano Terme, Padova, Italy. Electronic address: marco.marino@casacura.it.

Francesco Giovinazzo (F)

Department of Surgery, Transplantation Service, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy.

Mauro Podda (M)

Department of Surgery, Cagliari University Hospital D. Casula, Cagliari, Italy.

Marcos Gomez Ruiz (M)

Department of General and Digestive Surgery, Hospital Universitario Marqués de Valdecilla, Santander, Spain.

Manuel Gomez Fleitas (M)

Department of Robotics and Surgical Innovation, Hospital Universitario Marqués de Valdecilla, Santander, Spain.

Adolfo Pisanu (A)

Department of Surgery, Cagliari University Hospital D. Casula, Cagliari, Italy.

Mario Adelfio Latteri (MA)

Department of Surgical, Oncological and Oral Science, Palermo University Hospital, Palermo, Italy.

Kyoichi Takaori (K)

Department of General Surgery, Kyoto University Hospital, Shogoin, Sakyo-ku, Kyoto, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH